As the whole world is fighting against COVID-19, the demand for ventilators has emerged significantly in healthcare facilities. Ventilators are mechanical breathing devices that are used to blow oxygen and air into the lungs. These devices are important for delivering care to people suffering from lung failure, which is one of the complications among patients with severe COVID-19. Italy is among one of the nations requiring a significant number of ventilators amid COVID-19 to help patients breathe easier.
The global spread of coronavirus has put ventilator manufacturers under pressure to ramp up production. Due to the epidemic, the supply of essential components has disrupted, which include valves, hoses, and motors. In addition, most of the electronic products come from China which is further disrupting the production of ventilators. Owing to the shortages of supplies and production, the government of Italy are moving towards taking support from the military, contacting with other manufacturers. They are looking to 3D printing with the expectation of scaling up the production of the potentially life-saving breathing machines. A team of doctors in Italy has created a way of delivering oxygen to two people from a single ventilator, thereby doubling capacity. Further, Isinnova, an Italian research institute has expanded its efforts to solve a shortage of ventilator valves in some Italian hospitals using 3D printing.
The government asked ventilator manufacturers to meet the demand for ventilators. For instance, Siare Engineering International Group s.r.l. has augmented its ventilators output from 160 to 500 every month. The country is facing a major shortage of essential medical equipment, including ventilators, as death toll in the country surpassed 5,000. To increase the production of ventilators, Sierrais in discussion with Fiat and Ferrari to support in the production of more ventilators to fight COVID-19 outbreak in Italy. Automobile companies have a potential supply chain, which can support Siare to obtain parts for significant amount of ventilators production. Nearly 25 army technicians are working with Siare along with its production supervisors to support assemble machines and management of higher production.
The study on the effect of COVID-19 on Italy ventilator industry is segmented into portable and intensive care ventilators. Portable ventilators are in significant demand as they are regarded as superior to manual ventilation owing to the ability to reduce the risk of ventilator-induced lung injury while achieving control and constant monitoring of airway pressures and tidal volumes. The usage of a transport ventilator are considered as useful for intensive care unit (ICU) patients that needs an extreme level of ventilator support. Koninklijke Philips N.V. has stated that the most required product for multiple respiratory conditions includes portable ventilators, vital signs monitors, and medical equipment. As a result of coronavirus epidemics, the company is targeting a four-fold rise in the ventilator output by the third quarter of March to fulfil the demand from hospitals for patients suffering from the condition.
The major companies providing support to Italy include Siare Engineering International Group S.p.A., General Electric Co., Getinge AB, and Drägerwerk AG & Co. KGaA. To cope up with the global demand, these companies have increased their ventilators production capability. For instance, Getinge AB declared that it will deliver 500 ventilators to Italy coupled with the intensifying demand. The government of Italy has also purchased approximately 5,000 units of ventilators it tendered for earlier in March. In a single day, Dräger AG & Co. KGaA has shipped more than 100 ventilators from Germany to Italy. The company is coordinating closely with authorities to be able to continuously provide services in this difficult condition.
Research Methodology
OMR global recently published a report addressing the impact of COVID-19 on Italy ventilator industry. The study is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, laws and policies, consumer behavior and macro-economic factors. Besides, an expected recovery timeline of the industry will also be included with the best- and worst-case scenario which will aid clients to take their future steps in the decision-making process.
Sources Include
The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Government Initiatives
2.4. Demand and Supply Analysis
3. Industry Overview
3.1. Historical market growth estimation in Italy ventilator industry excluding COVID-19 pandemic effect
3.2. Deviations in the Italy ventilator industry growth rate due to COVID-19 pandemic
4. Segmentation
4.1. By Type
4.1.1. Portable
4.1.2. Intensive Care
5. Company Profile
5.1. Creanova S.r.l.
5.2. Drägerwerk AG & Co. KGaA
5.3. Fiat Chrysler Automobiles N.V.
5.4. General Electric Co.
5.5. Getinge AB
5.6. Hamilton Medical AG
5.7. Koninklijke Philips N.V.
5.8. Magneti Marelli S.p.A.
5.9. Medtronic plc
5.10. Siare Engineering International Group s.r.l.
5.11. Fisher & Paykel Healthcare Ltd.
5.12. ResMed Inc.
1. ITALY PORTABLE VENTILATOR INDUSTRY RESEARCH AND ANALYSIS, 2018-2025 ($ MILLION)
2. ITALY INTENSIVE CARE VENTILATOR INDUSTRY RESEARCH AND ANALYSIS, 2018-2025 ($ MILLION)
1. ITALY PORTABLE VENTILATOR INDUSTRY TREND PRE AND POST COVID-19, 2018-2025 (%)
2. ITALY INTENSIVE CARE VENTILATOR INDUSTRY TREND PRE AND POST COVID-19, 2018-2025 (%)